Bloomberg - Read the article "Why We May Lose Generic Drugs"

MD HB 631 is Unconstitutional

The U.S. Court of Appeals for the Fourth Circuit agrees that Maryland’s HB 631 is unconstitutional because it violates the Commerce Clause of the U.S. Constitution.

View Statement
Wellness is Non-Partisan

Making drugs accessible and affordable for all Americans is one of the most critical issues facing our nation today.

Watch Video
Skyrocketing Drug Prices Are a Threat to Everyone

Use this infographic to learn how generics and biosimilars are a remedy to sky-high health care costs.

Read Blog
AAM White Paper

Ensuring the Future of Accessible Medicines in the U.S.

Read White Paper
Savings. Shared.

Explore the interactive map to find out how much generic drugs save you and your state in healthcare costs.

View Map
Medicaid Generics Penalty

This penalty could destabilize the robust market for generic drugs and impede patient access.

Learn More

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Apr 13, 2018 | Erik Komendant

Cotton-McCaskill PACED Act Would Help Patients Gain Access to More Affordable Generics

AAM Applauds House Passage of FDA User Fee Reauthorization

Apr 9, 2018 | Jeff Francer

AAM Has Adopted a Code of Business Ethics. Here’s What That Means.

Let's Bring Drug Prices Back to Earth

Mar 28, 2018 | Erica Klinger

Skyrocketing Drug Prices: What's Driving Up Costs?

AAM Membership Matters

Mar 1, 2018 | Jewel Smith

Why Membership Matters

Access! 2018 - Charles Cook, Jr. Addresses the Current Political and Legislative Environment

Feb 28, 2018 | Rachel Schwartz

Recap of Access! 2018 — Delivering on the Promise of Generics and Biosimilars (Part 3)

The 180-Day Rule Supports Generic Competition

Feb 27, 2018 | Erik Komendant

The 180-Day Rule Supports Generic Competition. Here’s How.